Alex J. Bott

1.8k total citations
12 papers, 670 citations indexed

About

Alex J. Bott is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Alex J. Bott has authored 12 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Biochemistry. Recurrent topics in Alex J. Bott's work include Cancer, Hypoxia, and Metabolism (8 papers), RNA modifications and cancer (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Alex J. Bott is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), RNA modifications and cancer (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Alex J. Bott collaborates with scholars based in United States, China and Taiwan. Alex J. Bott's co-authors include Wei‐Xing Zong, Sara Maimouni, Nadia Jaber, Ji-An Pan, Joseph M. Catanzaro, Yu Sun, Chunying Du, Jorge Moscat, Zhixun Dou and Keiko Ozato and has published in prestigious journals such as Journal of Clinical Investigation, Molecular Cell and Cell Metabolism.

In The Last Decade

Alex J. Bott

11 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex J. Bott United States 9 438 289 128 93 78 12 670
Salvador Naranjo‐Suarez Spain 15 539 1.2× 271 0.9× 110 0.9× 140 1.5× 90 1.2× 22 917
Yang‐An Wen United States 13 498 1.1× 394 1.4× 110 0.9× 109 1.2× 71 0.9× 16 763
Jianhui Ma China 5 444 1.0× 302 1.0× 112 0.9× 86 0.9× 70 0.9× 7 651
Min-Sik Lee South Korea 10 491 1.1× 166 0.6× 53 0.4× 179 1.9× 65 0.8× 14 629
Mingyao Huang China 15 565 1.3× 386 1.3× 119 0.9× 129 1.4× 192 2.5× 20 918
Yung-Sheng Chang Taiwan 9 383 0.9× 223 0.8× 144 1.1× 111 1.2× 56 0.7× 10 673
Michael Batie United Kingdom 14 522 1.2× 421 1.5× 39 0.3× 74 0.8× 108 1.4× 20 792
Alden C. Klarer United States 10 516 1.2× 418 1.4× 65 0.5× 130 1.4× 114 1.5× 12 731
Russell Ericksen United States 14 523 1.2× 271 0.9× 98 0.8× 305 3.3× 144 1.8× 22 1.0k
Annalisa Zecchin Belgium 10 449 1.0× 187 0.6× 44 0.3× 118 1.3× 104 1.3× 12 701

Countries citing papers authored by Alex J. Bott

Since Specialization
Citations

This map shows the geographic impact of Alex J. Bott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex J. Bott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex J. Bott more than expected).

Fields of papers citing papers by Alex J. Bott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex J. Bott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex J. Bott. The network helps show where Alex J. Bott may publish in the future.

Co-authorship network of co-authors of Alex J. Bott

This figure shows the co-authorship network connecting the top 25 collaborators of Alex J. Bott. A scholar is included among the top collaborators of Alex J. Bott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex J. Bott. Alex J. Bott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bott, Alex J., et al.. (2025). SLC7A5 is required for cancer cell growth under arginine-limited conditions. Cell Reports. 44(1). 115130–115130. 4 indexed citations
2.
3.
Dai, Weiwei, Jianliang Shen, Alex J. Bott, et al.. (2022). Glutamine synthetase limits β-catenin–mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1. Journal of Clinical Investigation. 132(24). 41 indexed citations
4.
Winter, Jacob M., Corey N. Cunningham, Heather R. Keys, et al.. (2022). Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction. eLife. 11. 10 indexed citations
5.
Peng, Wei, Alex J. Bott, Ahmad A. Cluntun, et al.. (2022). Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2–dependent glutaminolysis pathway. Science Advances. 8(39). eabq0117–eabq0117. 18 indexed citations
6.
Berg, Jordan A., Jonathan R. Belyeu, Jeffrey T. Morgan, et al.. (2020). XPRESSyourself: Enhancing, standardizing, and automating ribosome profiling computational analyses yields improved insight into data. PLoS Computational Biology. 16(1). e1007625–e1007625. 11 indexed citations
7.
Ruiz, Christian, et al.. (2020). SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC. The FASEB Journal. 34(8). 10574–10589. 17 indexed citations
8.
Bott, Alex J., Sara Maimouni, & Wei‐Xing Zong. (2019). The Pleiotropic Effects of Glutamine Metabolism in Cancer. Cancers. 11(6). 770–770. 93 indexed citations
9.
Pan, Ji-An, Alex J. Bott, Nadia Jaber, et al.. (2016). TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis. Molecular Cell. 61(5). 720–733. 217 indexed citations
10.
Peng, I‐Chen, Alex J. Bott, & Wei‐Xing Zong. (2016). Spectrophotometric Determination of Glutamine Synthetase Activity in Cultured Cells. BIO-PROTOCOL. 6(19). 5 indexed citations
11.
Bott, Alex J., I‐Chen Peng, Yongjun Fan, et al.. (2015). Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation. Cell Metabolism. 22(6). 1068–1077. 195 indexed citations
12.
Sheshadri, Namratha, Joseph M. Catanzaro, Alex J. Bott, et al.. (2014). SCCA1/SERPINB3 Promotes Oncogenesis and Epithelial–Mesenchymal Transition via the Unfolded Protein Response and IL6 Signaling. Cancer Research. 74(21). 6318–6329. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvador Naranjo‐Suarez Breakdown of academic impact, for papers by Yang‐An Wen Breakdown of academic impact, for papers by Jianhui Ma Breakdown of academic impact, for papers by Min-Sik Lee Breakdown of academic impact, for papers by Mingyao Huang Breakdown of academic impact, for papers by Yung-Sheng Chang Breakdown of academic impact, for papers by Michael Batie Breakdown of academic impact, for papers by Alden C. Klarer Breakdown of academic impact, for papers by Russell Ericksen Breakdown of academic impact, for papers by Annalisa Zecchin
Rankless by CCL
2026